Here's our daily look at three charts linked to recent news-driven price moves, with key technical levels to watch.
During the bull market of 2023, the “Magnificent Seven” stocks have dominated financial media coverage, and rightly so. There is no question that this group of companies has been performing very w
IQVIA (IQV) aims at market expansion through innovation and service improvements.
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
IQVIA is a global provider of contract research services and data analytics for the healthcare industry. The company helps clients drive healthcare forward by providing insights and solutions to impro

IQVIA Holdings (IQV) Q3 Earnings Surpass Estimates

09:46am, Wednesday, 01'st Nov 2023
IQVIA Holdings (IQV) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $2.48 per share a year ago.
IQVIA's (IQV) revenues are likely to increase year over year on the back of improving segmental performance.
Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2023 financial results before the market opens on Wednesday, November 1, 202
IQVIA (IQV) and argenx expand collaboration to advance rare autoimmune treatments through innovative pharmacovigilance.
A federal court on Friday struck down a rule that sharply increased out-of-pocket prescription costs for many patients with complex conditions.
An addressable market size and strong healthcare-specific global IT infrastructure boost IQVIA (IQV).
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Morgan Stanley An
IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
This year has not been kind to biotech stocks, as the sector's most popular ETF, the iShares Biotechnology ETF (NASDAQ: IBB ), has fallen about 3% so far in 2023. Investors are probably worried about
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE